Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

daunomycin hydrochloride

(DAW-noh-MY-sin HY-droh-KLOR-ide)
A drug that comes from the bacterium Streptomyces coeruleorubidus and is used with other drugs as remission induction therapy to treat adults with acute myeloid leukemia and adults and children with acute lymphoblastic leukemia. It is also being studied in the treatment of other types of cancer. Daunomycin hydrochloride blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. It is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Daunorubicin is the active ingredient of daunorubicin hydrochloride. Also called daunorubicin hydrochloride.
More Information
Search NCI's Dictionary of Cancer Terms